Freedom Broker Maintains Buy on Niagen Bioscience, Lowers Price Target to $6

Benzinga · 1d ago
Freedom Broker analyst Ilya Zubkov maintains Niagen Bioscience (NASDAQ:NAGE) with a Buy and lowers the price target from $8.5 to $6.